Genetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology News (GEN) was the first publication in the field and remains the key driver in the explosion of the industry, paving the way for the development of new technologies and applications, investment and funding growth, and career opportunities. For more than 40 years, GEN has maintained unparalleled integrity, influence, and expertise that plays a pivotal role in driving the productivity and growth of the industry.
The exclusive features, reporting, and analysis in GEN enable new scientific discoveries, accelerate the pace of research, and drive large-scale funding and investments. A site-wide license enables end users across myriad disciplines to translate research into real-world applications and to understand the impact of the developments driving the future of biotechnology.
GEN coverage includes:
Drug Discovery
Assay Development
Cancer Research
Cannabis
Animal Models
Infectious Diseases
Cancer Research
Immunotherapy
Cell Therapy
Oncogenes
Tumor Suppressor
Genes
Rational Drug Design
Monoclonal
Antibodies
OMICS
Sequencing
Mass Spectrometry and Proteomics
Spatial Biology
Metabolomics
Genomics
Forensics
Epigenetics
Infectious Diseases
Vaccine Development
Virology
COVID-19
RNA Vaccines
Genome Editing
CRISPR
Agbiotech
Gene Therapy
RNA Editing
Synthetic Biology
Base Editing
Translational Medicine
Liquid Biopsy
Molecular Diagnostics
Biomarkers
Microbiome
Nanotechnology
Microfluidics
Stem Cells
Bioprocessing
Bioprocessing 4.0
Cell Manufacturing
Gene Therapy
Manufacturing
Viral Safety
Gene Expression
Glycobiology
Artificial Intelligence
Machine Learning
Big Data
Informatics
Neural Networks
High-performance Computing
| Kevin Davies, MD | Washington, DC, USA |
| Pete Gagnon | Chief Scientific Officer BIA Separations |
| David Giljohann, PhD | AuraSense, Evanston, IL, USA |
| Uwe Gottschalk, PhD | Chief Scientific Officer Lonza |
| Harry E. Gruber, MD | CEO, Tocagen |
| James Inglese, PhD | Principal Investigator, National Center for Advancing Translational Sciences |
| Guenter Jagschies | Senior Director, GE Healthcare Life Sciences |
| Cigall Kadoch, PhD | Assistant Professor, Dept. of Pediatric Oncology, Dana Farber Cancer Institute and Harvard Medical School |
| Anis H. Khimani, PhD | Head of Strategy and Marketing Research, Reagent Solutions PerkinElmer |
| Ivan Liachko, PhD | CEO, Phase Genomics |
| Miodrag MIcic, ScD, PhD | Professor and Department Chairman, Cerritos College |
| Eric Schadt, PhD | Founder and CEO, Sema4 |
| Zhiwei Song, PhD | Scientist, Bioprocessing Technology Institute, Singapore |
| Ali Torkamani, PhD | Director of Genomics and Genome Informatics, Scripps Research Translational Institute |
| Fyodor, D. Urnov, PhD | Deputy Director, Altius Institute |
| Bin Wang, PhD | Professor Principal Investigator, Shanghai University Medical College |